Latest Content


Why AI Can't Replace the Human Patient Experience
0:51
Why AI Can't Replace the Human Patient Experience
5 hours ago
by
Mike Hollan(+1 more)
Dr. Brian Corgiat
1:10
Why Cancer Tumors Change Over Time
8 days ago
by
Mike Hollan(+1 more)
Market Movers RX
1:16
Market Movers RX: Moderna's Bounce Back
11 days ago
by
Nicholas Jacobus
Closing the R&D-to-Manufacturing Handoff
1:03
Closing the R&D-to-Manufacturing Handoff
12 days ago
by
Michael Christel(+1 more)
John Stanford
1:02
The Constraints of Midsize Pharma
13 days ago
by
Mike Hollan(+1 more)
Beyond the Midterms: States Driving Pharma Policy Debate
1:04
Beyond the Midterms: States Driving Pharma Policy Debate
14 days ago
by
Michael Christel(+1 more)
Hamish Brocklebank
0:47
Retiring the Term Digital Twin for Digital Clones
15 days ago
by
Mike Hollan(+1 more)
Marc Wagner
Manufacturing Drugs vs. Baking a Cake
20 days ago
by
Mike Hollan(+1 more)
Exec on Execs
1:27
What's Shifting and What's Staying the Same
22 days ago
by
Mike Hollan
Market Movers RX
1:14
Market Movers RX: Car Zeiss Meditec Leads Gainers
25 days ago
by
Nicholas Jacobus

2026 Emerging Pharma Leaders

From guiding pursuits in artificial intelligence and R&D to scientific marketing and company building, meet Pharm Exec’s new slate of select rising leaders who are helping to shape the next generation of biopharma innovation.

2026 Emerging Pharma Leaders

Finding the Universal Truth in a Drug's Story

Sarah Ghosh, U.S. scientific marketing lead in oncology at Regeneron, discusses developing and adapting the narrative for a medication for every global market.

Finding the Universal Truth in a Drug's Story

Preventing Cardiovascular Disease Through Mission-Driven Leadership

Rena Denoncourt, chief operating officer at Corsera Health, discusses the operational challenges of building a startup and how she balances prioritization with the flexibility drug development demands.

Preventing Cardiovascular Disease Through Mission-Driven Leadership

What C-Suite Readiness Really Requires

Dr. Nick Botwood, chief medical officer and head of research and development at Syndax Pharmaceuticals, draws on his career to explain what separates good R&D organizations from great ones.

What C-Suite Readiness Really Requires

Two Decades of Technology Transformation in Pharma

Abid Rahman, head of AI Agency and innovation at EVERSANA, explains how the pharmaceutical industry is moving from generative to agentic AI.

Two Decades of Technology Transformation in Pharma

Podcasts



All News

Pharmaceutical Executive Daily

FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.

Pharmaceutical Executive Daily

FDA approves Merck KGaA’s Pimjetmi for tenosynovial giant cell tumor, Parexel’s Stacy Hurt on when patient input should enter the clinical research process, and Ignite Proteomics’ Dr. Brian Corgiat on adjusting for tumor mutations in treatment decisions.